|
A. Original Articles
1. Soprano DR, Herbert J, Soprano KJ, Schon EA and Goodman DS. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 269: 11793 (1985).
2. Herbert J , Wilcox JN, Pham KC, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell Award. Neurology 36: 900 (1986).
3. Kato M, Soprano DR, Makover A, Kato K, Herbert J and Goodman DS. Localization of immunoreactive transthyretin and transthyretin mRNA in fetal and adult rat brain. Differentiation 31: 228 (1986).
4. Zeviani M, Herbert J, Sherbany A, DiMauro S and Schon EA. Isolation of a cDNA clone encoding subunit IV of human cytochromec oxidase. Gene 55: 205 (1987).
5. Stylianopoulou F, Herbert J , Soares MB and Efstratiadis A. Insulin-like growth factor II gene expression in the choroid plexus and leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci USA 85:141 (1988).
6. Martone RL, Herbert J, Dwork AJ and Schon EA. Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 151: 905 (1988).
7. Stylianopoulou F, Efstratiadis A, Herbert J and Pintar J. Pattern of insulin-like growth factor II gene expression during rat embryogenesis. Development 103:497 (1988).
8. Dwork AJ, Schon EA and Herbert J . Non-identical distribution of immunoreactive transferring and ferric iron in human brain. Neuroscience 27:333 (1988).
9. Pezzoli G, Fahn S, Dwork A, Truong DD, DeYebenes JG, Jackson-Lewis V, Herbert J and Cadet JL. Non-chromaffin tissue plus nerve growth factor reduces experimental Parkinsonism in aged rats. Brain Res 459:398 (1988).
10. Martone RL, Schon EA, Soprano DR, Goodman DS and Herbert J. Retinol-binding protein is synthesized in the mammalian eye. Biochem Biophys Res Commun 157:1078 (1988).
11. Mita S, Sadlock J, Herbert J and Schon EA. A cDNA specifying the human amyloid beta precursor protein (ABPP) encodes a 95-kDa polypeptide. Nucl Acids Res, 16: 9351 (1988).
12. Mena MA, De Yebenes JG, Dwork A, Fahn S, Latov N and Herbert J. Biochemical properties of monoamine rich neuroblastoma cells. Brain Research 486:286 (1989).
13. Mita S, Schon EA and Herbert J. Widespread expression of amyloid beta protein precursor gene in rat brain. Amer J Pathol 134:1253 (1989).
14. Cavallaro T, Martone RL, Dwork AJ, Schon EA and Herbert J . The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Investigative Ophthalmology & Visual Science, 31(3):497 (1990).
15. Dwork AJ, Cavallaro T, Martone RL, Goodman DS, Schon EA, and Herbert J. Distribution of transthyretin in the rat eye. Invest Ophthalmol Vis Sci 31(3):489 (1990).
16. Herbert J , Cavallaro T and Dwork AJ. A marker for primary choroid plexus neoplasms. Amer J Pathol 136:1317 (1990).
17. Herbert J , Cavallaro T and Martone RL. Distribution of retinol-binding protein and its mRNA in rat eye. Invest Opthalmol Vis Sci 32:302 (1991).
18. Mizuno R, Cavallaro T and Herbert J. Temporal expression of the transthyretin gene in the developing rat eye. Invest Ophthalmol Vis Sci 33:341 (1992).
19. Izumoto S, Younger D, Martone RL, Smith RT and Herbert J Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation. Neurology 42:2094 (1992).
20. Seliger GM, Hornstein A, Flax J, Herbert J and Schroeder K. Fluoxetine improves emotional incontinence. Brain Inj 6:267 (1992).
21. Cavallaro T, Martone- RL, Stylianopoulou F and Herbert J. Differential expression of the insulin-like growth factor II and transthyretin genes in the developing rat choroid plexus. J Neuropath Exp Neurol 52:153 (1993).
22. Hatterer JA, Herbert J, Hidaka C, Roose SP and Gorman JM. CSF transthyretin in patients with depression. Amer J Psychiatry 150(5):813 (1993).
23. Izumoto S and Herbert J. Widespread constitutive expression of heat-shock protein 90 mRNA in rat brain. J Neurosci Res 35:20 (1993).
24. Martone RL and Herbert J. Mammalian pineal gland synthesizes transthyretin and retinol-binding protein. In preparation.
25. Cosman F, Nieves J, Herbert J, Shen V,and Lindsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Min Res 9(7):1097 (1994).
26. Valiquette G, D'Alisera P and Herbert J . Desmopressin in the management of nocturia in multiple sclerosis. A double-blind cross-over trial. Arch Neurol 53:1270 (1996).
27. Nieves J, Cosman F, Herbert J, Shen V and Lindsay R. High prevalaence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 44 (9):1687 (1994).
28. Higasawa S, Ferguson-Pell M and Herbert J. Quantitative assessment of capillary blood flow in patient with mutliple sclerosis. J Rehabil Res Dev 31(3):178 (1994).
29. Martone RL and Herbert J. Role of cationic metals in transthyretin-amyloid fibrillogenesis. In preparation.
30. Chen X, Yan S, Fu J, Eisenberger E and Herbert J. Genetic assay for multimerization of normal and mutant transthyretin. Amyloid 3:245 (1996).
31. Herbert J and Devinsky O. Rehabilitation after brain injury: Impact of posttraumatic epilepsy. Neurorehabilitation 5:269 (1995).
32. Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R. Reduced bone mass and fat-free mass in patients with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcified Tissue International 61:129-33 (1997).
33. Cosman F, Nieves J, Komar L, Ferrer G, Herbert J et al: Fracture history and bone loss in patients with MS. Neurology 51(4):1161-5 (1998).
34. Schwartz CE, Vollmer T, Lee H and the North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 52(1);63-70(1999).
35. Sullivan G, Hatterer J, Herbert J et al. Low levels of transthyretin in cerebrospinal fluid of depressed patients. Am J. Psychiatry 156(5):710(1999).
36. Mahon D, Herbert J, Sadiq S, Miller J, Madonna M, Hirano M. Leber’s Hereditary Optic Neuropathy Mitochondrial DNA Mutations at Nucleotides 11778 and 3460 in Multiple Sclerosis. Ophthalmologica 213(3):71-5 (1999).
37. Jacobs LD, Wende K, Herbert J, et al. A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium. Multiple Sclerosis 5, 369-376 (1999).
38. Waubant E, Hietpas J, Stewart T, et al. Tolerability of Interferon Beta-1a in Chidren with Multiple Sclerosis. (Submitted)
B. CASE REPORTS AND LETTERS
37. Abarbanel J, Herbert J, Dollberg J and Kupperman O. Peripheral neuropathy in dysglobulinemic states. Harefuah 98:364 (1980).
38. Rosin AJ, Van Dijk YM, Grafstein I and Herbert J. Hepatosplenomegaly as a manifestation of quinidine hypersensitivity. Age and Aging 4:253 (1980).
39. Schurr D, Herbert J, Habibi E and Abrahamov A. Unusual presentation of vitamin A intoxication. J Ped Gastroenterol Nutrit 2:705 (1980).
40. McCann P, Herbert J, Feldman F and Kelly MA. Neuropathic arthropathy associated with Neurofibromatosis- A Case Report. J Bone Joi Surg 74-A:1411 (1992).
41. Flax JW, Gray J and Herbert J. Effect of fluoxetine on patients with multiple sclerosis (letter). Amer J Psychiatr 148:1603 (1991).
42. Valiquette G, Abrams and Herbert J . DDAVP in the management of nocturia in multiple sclerosis (letter). Ann Neurol 31:577 (1992).
C. REVIEWS, CHAPTERS AND EDITORIALS
43. Herbert J. The familial amyloidotic polyneuropathies. In: Rowland LP, ed: Molecular Genetics in Diseases of Brain, Muscle and Nerve. Oxford Press, 1988. Chapter 22. pp 298-325.
44. Marks J, Lin T, Miller D, Lozano G, Herbert J and Levine AJ. The expression of cellular genes in papillomas of the choroid plexus induced in transgenic mice. In: Progress in clinical and biological research, vol 284: Cellular factors in development and differentiation. Alan R. Liss Inc, New York, 1988.
45. Pevny L, Mita S, Schon EA, Herbert J, Mayeux R, Yu MT and Smith CL. Chromosome 21 sequences are not duplicated in Alzheimer's disease: an analysis by pulsed field gel electrophoresis. Biotechnology and Human Genetic Predisposition to Disease. Wiley Liss Inc, 1990: pp21-28.
46. Martone RL, Benson MD and Herbert J. Myelin P2 protein in transthyretin (Ser-84) amyloid. In: Amyloid and Amyloidosis. JB Natvig, OForrem G Husby et al., eds. Kluwer Academic Publications, Dordrecht, 1990, pp655-658.
47. Herbert J. Familial amyloidotic polyneuropathy. In: The Molecular Genetic Basis of Neurologic Disease, 2nd ed. R. Rosenberg, S. DiMauro, et al, eds. Butterworth, Newton, MA, 1996. Chapter 48, pp pp845-864.
48. Martone RL and Herbert J. Metallo-protein interactions in TTR-amyloidogenesis: therapeutic implications. Amyloid and Amyloidosis 1993. Parthenon, New York. Section 8, pp517-520.
49. Martone RL and Herbert J. Transthyretin interacts with globin to form protein complexes with heme-dependent solubility.Amyloid and Amyloidosis 1993.Parthenon,New York. Section 8,pp532-534.
50. Martone RL and Herbert J . A peripheral nerve-specific protein binds the amyloidogenic domain of the Alzheimer's beta protein. Amyloid and Amyloidosis 1993. Parthenon, New York. Section 5, pp386-389.
51. Herbert J , Younger D, Latov N and Martone RL. Clinical spectrum of familial amyloidotic polyneuropathy. Amyloid and Amyloidosis 1993. Parthenon, New York. Section 6, pp486-488.
D. ABSTRACTS
Over 100 published scientific abstracts.
1. Herbert J, Sotrel A, Brody B and Welch K. Monstrocellular astrocytomas of early onset. J Neuropath Exp Neurol 43: 319 (1984).
2. Sotrel A, Herbert J, Kuban K and Ronthal M. Acute pseudotumoral demyelinating disorder in children and young adults. Schilder's disease or a variant of multiple sclerosis? J Neuropath Exp Neurol 43: 338 (1984).
3. Herbert J, Wilcox JN, Soprano DR, Roberts J, Goodman DS and Schon EA, Specific localization of transthyretin mRNA in rat choroid plexus: demonstration by in situ hybridization. Soc Neurosci Abstr vol 11, part 2: 841 (1985).
4. Zeviani M, Herbert J, Sherbany A, DiMauro S and Schon EA. Isolation of a cDNA clone encoding subunit IV of cytochrome c oxidase. Neurology 36:78 (1986).
5. Martone RL, Herbert J, Dwork A, Goodman DS and Schon EA. Intraocular transthyretin synthesis explains ocular involvement in familial amyloidotic polyneuropathy. Ann Neurol 22: 149 (1987). 6.Dwork AJ, Schon EA and Herbert J. Widespread distribution of transferring immunoreactivity in human brain. Soc Neurosci Abstr, vol 13, part 2: 1251 (1987).
7. Mena MA, De Yebenes JG, Dwork A, Latov N, Fahn S and Herbert J. Neuroblastoma cells as soon possible donor for transplantation in animal models of Parkinson's disease. Soc Neurosci Abstr vol 13, part 1: 162 (1987).
8. Herbert J, Pham KC,- Wilcox JN, Fremeau RT, Martone RL, Soprano DR, Roberts JL and Schon EA. Transthyretin (prealbumin) synthesis in choroid plexus papillomas. Neurology 37: 288 (suppl 1); (1987).
9. Schon EA, Mita S, Pevny L, Herbert J, Mayeux R, Yu MT and Smith C. Is there gene duplication in Alzheimer disease? An analysis using pulsed field gel electrophoresis. Neurology 38 (suppl 1): 116 (1988).
10. De Yebenes JG, Mena MA, Dwork A, Latov N, Fahn S and Herbert J. Transplanting human neuroblastoma cells in 6-hydroxydopamine lesioned rats. Neurology 38 (suppl 1): 128 (1988).
11. Dwork AJ, Cavallaro T, Martone R, Goodman DS, Schon EA and Herbert J. Distribution of transthyretin in the rat eye. Neurology 38 (suppl 1): 202 (1988).
12. Dwork AJ, Malkin K, Vallejos H and Herbert J. Plasma protein immunoreactivity in brain tumors. Neurology 38 (suppl 1): 209 (1988).
13. Herbert J, Schon EA, Vallejos H and Dwork AJ. Transthyretin is a marker for choroid plexus neoplasms. Neurology 38 (suppl 1): 213 (1988).
14. Mita S, Schon EA and Herbert J. Widespread expression of amyloid beta protein gene in rat brain. Neurology 38 (suppl 1): 232 (1988).
15. Stylianopoulou F, Herbert J, Soares MB and Efstratiadis A. Insulin-like growth factor II - an endogenous growth factor in adult rat brain. Neurology 38 (suppl 1): 233 (1988).
16. Herbert J. The choroid plexus as a paracrine organ. Neurology 38 (suppl 1): 273 (1988).
17. Dwork AJ, Schon EA and Herbert J. Distribution of transferrin in human brain differs from that of ferric iron. Neurology 38 (suppl 1): 273 (1988).
18. Martone R, Herbert J, Soprano DR and Schon EA. Retinol-binding protein is synthesized in rat eye. Neurology 38 (suppl 1): 394 (1988).
19. Herbert J, Cavallaro T, Vallejos H, Schon EA and Dwork AJ. A specific biochemical marker for choroid plexus tumors. J Neuropath Exp Neurol 47: (1988)
20. Cavallaro T, Dwork AJ, Martone RL, Schon EA and Herbert J. Retinal pigment epithelium is the unique site of transthyretin synthesis in rat eye. J Neuropath Exp Neurol
21. Dwork AJ, Scnon EA and Herbert J. Nonidentical distribution of transferrin and iron in human brain suggest novel roles for transferrin. J Neuropath Exp Neurol 47:(1988)
22. Herbert J, Stylianopoulou F and Dwork AJ. The choroid plexus: "liver" of the brain? Clin Neuropath 4: 171 (1988).
23. Cavallaro T and Herbert J. Utility of in situ hybridization in neuropathological diagnosis. Clin Neuropath 4: 153 (1988).
24. Cavallaro T, Martone R, Dwork A, Goodman DS, Schon EA and Herbert J. Synthesis of retinol transport proteins in the retinal pigment epithelium of the rat. Clin Neuropath 4: 153 (1988).
25. Martone RL, Cavallaro T, Dwork A, Goodman DS, Schon EA and Herbert J. Intraocular synthesis of serum retinol binding protein and transthyretin. Soc Neurosci Abstr 14 (part 1): 357 (1988).
26. Cavallaro T, Martone RL and Herbert J. Transthyretin gene expression in the developing rat choroid plexus and eye. Neurology 39 (Suppl 1): 343 (1989).
27. Cavallaro T, Martone RL and Herbert J. Primordial choroid plexus epithelium (CPE) expresses an intermediate phenotype between undifferentiated neuroepithelium and differentiated CPE. J Neuropathol Exp Neurol 48: 360 (1989).
28. Martone RL and Herbert J. Bovine pineal gland synthesizes transthyretin. Soc Neurosci Abstr 15 (part 1): (1989).
29. Herbert J, Martone RL, Cavallaro T, Dwork AJ and Schon EA. Intraocular synthesis of transthyretin. Abstracts of the First International Symposium on Familial Amyloidotic Polyneuropathy, Granja, Portugal (1989).
30. Herbert J. Transthyretin and amyloid: a model of autosomal dominant neurological disease. Neurology India (1989).
31. Valiquette G, Abrams G and Herbert J. DDAVP in the management of nocturnal incontinence in multiple sclerosis. Neurology 40 (Suppl 1):260 (1990).
32. Herbert J. DDAVP controls nocturia in multiple sclerosis. Abstracts of the third annual meeting of the Consortium of MS Centers, Denver, Colorado (1990).
33. Hornstein A, Flax J, Seliger G, Herbert J and Schroeder K. Treatment of emotional incontinence with fluoxetine. Presented, American Psychiatric Association, May 1990.
34. Flax J, Hornstein A, Seliger GM, Herbert J and Schroeder K. Fluoxetine treatment of emotional incontinence in multiple sclerosis. Presented, First Consultation and Liasion Psychiatry Research Forum, May 1990.
35. Seliger G, Herbert J, Hornstein A, Flax J and Schroeder K. Fluoxetine in the treatment of pseudobulbar affect. Neurology 40 (Suppl 1):327 (1990).
36. Herbert J, Martone RL, Schon EA and Cavallaro T. Rat pigment epithelium synthesizes transthyretin and retinol-binding protein. Invest Ophthalmol Vis Sci 31:111 (1990).
37. Herbert J, Hidaka C, Ehlers MRW and Caldwell PR. Angiotensin-converting enzyme is a marker for papillary neuroepithelial neoplasms. J Neuropath Exp Neurol 49:337 (1990).
38. Herbert J, Cavallaro T and Kupsky W. In situ hybridization analysis of transthyretin synthesis in 42 choroid plexus neoplasms. J Neuropath Exp Neurol 49:
39. Martone RL, Benson MD and Herbert J. Myelin P2 protein in transthyretin (Ser-84) vitreous amyloid. Abstracts of the 6th International Symposium on Amyloidosis (Oslo), p58 (1990).
40. Herbert J, Mizuno R and Cavallaro T. Transthyretin gene expression in the developing rat retinal pigment epithelium. Invest Ophthalmol Vis Sci 32:1011 (1991).
41. Martone RL, Benson MD, Schon EA and Herbert J. Transthyretin-amyloidosis: vitreous amyloid contains myelin P2 protein. Invest Ophthalmol Vis Sci 32:1136 (1991).
42. Hidaka C, Ehlers MRW, Caldwell PRB and Herbert J. Angiotensin-converting enzyme is a marker for papillary ependymomas. Neurology 41 (Suppl 1):131 (1991).
43. Cavallaro T, Martone RL and Herbert J. Differentiation of the choroid plexus. Neurology 41 (Suppl 1):306 (1991).
44. Martone RL, Benson MD, Schon EA and Herbert J. Familial amyloidotic polyneuropathy type II: Myelin P2 protein in vitreous amyloid. Neurology 41 (Suppl 1):340 (1991).
45. Mizuno R, Martone RL and Herbert J. Pineal gland synthesizes transthyretin. J Neuropath Exp Neurol (1991).
46. Izumoto S, Younger D, Hays AP, Hair L, Martone RL and Herbert J. Late-onset familial amyloidotic polyneuropathy: a new variant heterozygous for transthyretin (TTR) ASN-70. J Neuropath Exp Neurol (1991).
47. Martone RL, Benson MD, Schon EA and Herbert J. Myelin P2 protein is a component of ocular vitreous and vitreous amyloid: implications for amyloid fibrillogenesis in familial amyloidotic polyneuropathy (FAP). J Neuropath Exp Neurol (1991).
48. Mizuno R, Martone R, Ehlers M, Caldwell P and Herbert J. Angiotensin-converting enzyme mRNA in rat brain: Evidence for a striatonigral pathway. Neurology 42 (Suppl 3):152 (1992).
49. Martone Rl, Mizuno R and Herbert J. Synthesis of retinol transport proteins by the pineal gland. Neurology 42 (Suppl 3):170 (1992).
50. Izumoto S, Martone R, Younger D, Hays AP and Herbert J. Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation. Neurology 42 (Suppl 3):281 (1992).
51. Cosman F, Herbert J, Nieves J, Gordon S, Shen V and Lindsay R. Skeletal metabolism in multiple sclerosis: Effect of acute steroid administration. Neurology (Suppl 3):383 (1992).
52. Herbert J, Smith RT, Younger D, Hays AP, Martone RL and Izumoto S. Vitreous opacification in familial amyloidotic polyneuropathy: a new transthyretin mutation. Invest Ophthalmol Vis Sci 33:860 (1992).
53. Defoe D, Martone RL, Caldwell RB, Chang C-W and Herbert J. Transthyretin secretion by cultured retinal pigment epithelium. Invest Ophthalmol Vis Sci 33:911 (1992).
54. Martone RL, Mizuno R and Herbert J. Mammalian pineal gland synthesizes transthyretin and retinol-binding protein. Invest Ophthalmol Vis Sci 33:1182 (1992).
55. Herbert J, Younger D and Martone RL. Solubilization of transthyretin-amyloid fibrils by chelation: therapeutic implications. J Neuropath Exp Neurol (1992).
56. Mizuno R, Cavallaro T and Herbert J. Developmental expression of transthyretin mRNA in the rat brain and eye. Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.13 (1992).
57. Defoe DM, Martone RL, Caldwell RB, Chang C-W and Herbert J. Cultured rat retinal pigment epithelium secretes transthyretin. Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.14 (1992).
58. Martone RL, Mizuno R and Herbert J. The mammalian pineal is a synthetic site for transthyretin and retinol-binding protein. Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.15 (1992).
59. Izumoto S, Kornberg J and Herbert J. Two transthyretin mutations associated with euthyroid hyperthyroxinemia. Proc 2nd International Symposium Familial Amyloidotic Polyneuropathy, Sweden p.58 (1992).
60. Herbert J, Cavallaro T, Izumoto S, Martonr RL, Wolfe D and Kupsky W. Transthyretin synthesis in primary choroid plexus neoplasms. Proc 2nd International Syposium on Familial Amyloidotic Polyneuropathym Sweden p.59 (1992).
61. Izumoto S, Martone RL, Younger D, Hays AP and Herbert J. Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation: Asn 70. Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.66 (1992).
62. Martone RL and Herbert J. Interaction of transthyretin with metals I: Transthyretin binds divalent cations which influence its conformation and stability. Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.57 (1992).
63. Herbert J and Martone RL. Interaction of transthyretin with metals II: Metal chelation solubilizes transthyretin- amyloid. Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.42 (1992).
64. Martone RL, Benson MD and Herbert J. Myelin P2 protein is specifically associated with vitreous amyloid from patients with familial amyloidotic polyneuropathy (TTR Ser 84). Proc 2nd International Symposium on Familial Amyloidotic Polyneuropathy, Sweden p.41 (1992).
65. Izumoto S, Martone RL, Wolfe D and Herbert J. Cultured choroid plexus carcinoma forms papillae which synthesize and secrete transthyretin. J Neuropathol Exp Neurol (1992).
66. Wolfe D, Herbert J, Izumoto S, Rosenblum M and Moore F. Angiomatoid choroid plexus epithelioma: ultrastructural, immunohistochemical and molecular diagnosis. J Neuropathol Exp Neurol (1992).
67. Martone RL and Herbert J. FAP: Possible role for metals in pathogenesis. Neurology (Suppl) 43:A175 (1993).
68. Herbert J and Martone RL. FAP: Chelations solubilizes TTR-amyloid fibrils in vitro. Neurology (Suppl) 43:A175 (1993).
69. Isozaki E, Rosoklija G, Neri D, Herbert J and Hays AP. Two different forms of amyloid in polyneuropathy activate the classical complement pathway. Neurology (Suppl) 43:A232 (1993).
70. Valiquette G, Meade-D'Alisera P and Herbert J. Double-blind crossover trial of DDAVP for nocturia in MS. Neurology (Suppl) 43:A281 (1993).
71. Martone RL and Herbert J. Transthyretin is a metal-binding protein: Implications for vitreous amyloidosis. Invest Ophthalmol Vis Sci 35:1041 (1993).
72. Herbert J, Younger D, Latov N and Martone RL. Clinical spectrum of amilial amyloidotic polyneuropathy. Abstracts of the 7th International Symposium on Amyloidosis, Ontario. (1993).
73. Martone RL and Herbert J. Metallo-protein interactions in TTR-amyloidogenesis: therapeutic implications. Abstracts of 7th International Symposium on Amyloidosis, Ontario (1993).
74. Martone RL and Herbert J. Tranthyretin interacts with globin to form protein complexes with heme-dependent solubility. Abstracts of 7th International Symposium on Amyloidosis, Ontario (1993).
75. Martone Rl and Herbert J. A peripheral nerve-specific protein binds the amyloidogenic domain of the Alzheimer's beta protein. Abstracts of 7th International Symposium on Amyloidosis, Ontario (1993).
76. Herbert J, Younger D, Latov N and Martone RL. Clinical spectrum of familial amyloidotic polyneuropathy. Neurology (Suppl 2) 44:A307 (1994)
77. Ferguson-Pell M, Hagisawa S and Herbert J. Reactive hyperemia response in patients with MS using tissue reflectance spectroscopy. Neurology (Suppl 2) 44:A314 (1994)
[ top ]
|
